NCT02450149View on ClinicalTrials.gov

Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid Tumors

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 30, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

August 9, 2016

Conditions

Refractory Solid Tumors

Interventions

DRUG

sorafenib

Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors

lead

Samsung Medical Center

OTHER

NCT02450149 - Single-arm Study to Evaluate the Safety and Efficacy of Sorafenib, in Subjects With BRAF Mutation Refractory Solid Tumors | Biotech Hunter | Biotech Hunter